Descrizione

Alpha and beta diversity analysis of gut microbiota composition in irritable bowel syndrome patients versus healthy controls. The multicenter amplicon sequencing approach integrates data across multiple cohorts to assess microbial community differences.

Figure 1

Chart

Source Paper

Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.

Journal of translational medicine (2023)

PMID: 36774467

DOI: 10.1186/s12967-023-03953-7

Cite This Figure

![Figure 1: Alpha and beta diversity analysis of gut microbiota composition in irritable bowel syndrome patients versus healthy controls. The multicenter amplicon sequencing approach integrates data across multiple cohorts to assess microbial community differences.]()

> Source: Han Chen et al. "Alternation of the gut microbiota in irritable bowel syndrome: an integrated ana." *Journal of translational medicine*, 2023. PMID: [36774467](https://pubmed.ncbi.nlm.nih.gov/36774467/)

<figure>
  <img src="" alt="Alpha and beta diversity analysis of gut microbiota composition in irritable bowel syndrome patients versus healthy controls. The multicenter amplicon sequencing approach integrates data across multiple cohorts to assess microbial community differences." />
  <figcaption>Figure 1. Alpha and beta diversity analysis of gut microbiota composition in irritable bowel syndrome patients versus healthy controls. The multicenter amplicon sequencing approach integrates data across multiple cohorts to assess microbial community differences.<br>  Source: Han Chen et al. "Alternation of the gut microbiota in irritable bowel syndrome: an integrated ana." <em>Journal of translational medicine</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36774467/">36774467</a></figcaption>
</figure>

Evidenze correlate

Bifidobacterium longum per Irritable Bowel Syndrome (IBS)

Grado B · 4 studi

Bifidobacterium breve per Irritable Bowel Syndrome (IBS)

Grado D · 2 studi